What are peptides
Peptides are short chains of amino acids, typically consisting of 2-50 amino acids linked by peptide bonds. They serve as signalling molecules in the body, influencing a wide range of physiological processes including tissue repair, immune function, metabolism, and hormonal regulation.
Unlike larger proteins, peptides are small enough to be absorbed and utilised efficiently by the body. Their specific amino acid sequences determine their biological activity, making them highly targeted in their effects compared to broader-acting compounds.
How peptides are commonly used
In clinical and research settings, peptides are studied across multiple domains including recovery and tissue repair (BPC-157, TB-500), growth hormone optimisation (CJC-1295, Ipamorelin), skin and collagen synthesis (GHK-Cu), metabolic regulation (Semaglutide), and cognitive support (Selank, Semax).
Administration methods vary by compound but commonly include subcutaneous injection using insulin-type syringes. Dosing protocols are typically structured in cycles with defined on and off periods to maintain efficacy and allow for monitoring.
Safety and quality: what matters
The peptide market varies significantly in quality. Key factors that distinguish high-quality peptides include purity levels (98%+ for research-grade compounds), independent third-party testing, proper manufacturing standards, and appropriate cold-chain storage throughout distribution.
Consumers should be wary of products without documentation, unusually low pricing, or suppliers who cannot provide Certificates of Analysis. Medical supervision is strongly recommended for any peptide protocol to ensure appropriate use and monitoring.
Independent lab testing and batch quality
Independent laboratory testing verifies peptide identity, purity, and absence of contaminants. Testing methods include High-Performance Liquid Chromatography (HPLC) for purity assessment, Mass Spectrometry for identity confirmation, and sterility testing for injectable preparations.
Batch-specific Certificates of Analysis should accompany each product, allowing consumers to verify the exact batch they receive has been tested. This documentation should be readily available from the supplier.
Protocols vs single products
A protocol-based approach structures peptide use into defined programs with specific combinations, timing, and duration. This differs from ad-hoc single-product use by providing systematic guidance based on research frameworks and clinical experience.
Protocols typically account for synergistic effects between compounds, appropriate cycling to prevent tolerance, and structured monitoring points. This approach supports more predictable outcomes and safer use compared to unstructured experimentation.
Storage and handling basics
Proper storage is essential for maintaining peptide stability and efficacy. Lyophilised (freeze-dried) peptides should be stored at 2-8°C in their original sealed vials, protected from light. Under these conditions, most peptides remain stable for extended periods.
Once reconstituted with bacteriostatic water, peptides should be refrigerated and used within the specified timeframe—typically 4-6 weeks depending on the compound. Avoid freezing reconstituted peptides as this can damage the molecular structure.
Frequently asked questions
In Australia, peptides are regulated as prescription-only medicines under the Therapeutic Goods Administration (TGA). This means they require a valid prescription from an Australian-registered medical practitioner. Possession without a prescription may be subject to regulatory enforcement.
Yes. Most therapeutic peptides in Australia are classified as Schedule 4 (prescription-only) medicines. A consultation with a registered practitioner is required to assess suitability and issue a prescription where clinically appropriate.
High-quality peptides should come with independent third-party lab testing (Certificate of Analysis), clear documentation of purity levels (typically 98%+ for research-grade), proper cold-chain storage, and transparent sourcing from TGA-licensed or equivalent facilities.
Yes. Every batch of Zenith peptides undergoes independent third-party testing. Certificates of Analysis are available for each product, showing purity, identity confirmation, and absence of contaminants.
Unreconstituted peptides should be stored in a refrigerator at 2-8°C, protected from light. Once reconstituted with bacteriostatic water, they should remain refrigerated and typically used within 4-6 weeks depending on the specific compound.
A protocol-based approach structures peptide use into defined cycles with specific timing, dosing, and duration parameters. This systematic method is designed to optimise outcomes while supporting safety monitoring and adjustment based on individual response.
How Zenith approaches peptide optimisation
Zenith Performance operates within Australia's clinical pathway framework, connecting individuals with registered practitioners for assessment and prescription where appropriate. Every peptide batch undergoes independent third-party testing with certificates available for verification.
Our protocol-based system structures peptide use into evidence-informed programs, supported by documentation and guidance. The 10mL refill system is designed for convenience while maintaining proper cold-chain storage and quality standards throughout.
Related Categories
Related Guides
Ready to get started?
Explore our structured protocols or browse individual peptides with independent lab testing.